{
    "code": "22000001",
    "time": "2015-06-22 01:44:41",
    "許可證字號": "罕菌疫輸字第000001號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "105\/05\/28",
    "發證日期": "90\/05\/28",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA02200000100",
    "中文品名": "立比扶注射劑 22 MCG",
    "英文品名": "REBIF 22 MICROGRAMS",
    "適應症": "復發型多發性硬化症。",
    "劑型": "270注射劑",
    "包裝": "盒裝 注射針筒",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "INTERFERON BETA-1A",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1419601100  臺灣默克股份有限公司",
    "申請商地址": "台北市內湖區堤頂大道2段89號6樓",
    "主製造廠": {
        "製造廠名稱": "F250324000  MERCK SERONO S.P.A.",
        "製造廠廠址": "VIA DELLE MAGNOLIE 15, ZONA INDUSTRIALE DI MODUGNO, 70026 MODUGNO, ITALY",
        "製造廠公司地址": "",
        "製造廠國別": "ITALY",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818000740",
            "成分名稱": "INTERFERON BETA-1A",
            "含量描述": "",
            "含量": "22.0000000000",
            "單位": "MCG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 Rebif 22&44 mcg leaflet final-104-03-30.pdf 220000010006.jpg 220000010005.jpg 220000010004.jpg 220000010003.jpg 220000010002.jpg 220000010001.jpg 100000010002___20110316.pdf 100000010001___20110316.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=22000001&Seq=009&Type=9"
        },
        {
            "title": "外盒 220000010004.jpg 220000010003.jpg 220000010002.jpg 220000010001.jpg 100000010002___20110316.pdf 100000010001___20110316.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=22000001&Seq=006&Type=8"
        }
    ]
}